The ARUBA trial: current status, future hopes.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 20634478.
- Also identified by DOI 10.1161/STROKEAHA.110.580274 and PMC identifier 2927344.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Report on the status of an on-going National Institutes of Neurological Disorders and Stroke (NINDS)-supported clinical trial of management of unbled brain arteriovenous malformations. Begun in April 2007 with 3 centers, the trial has grown to 65 centers, and has randomized 124 patients through mid-June 2010 en route to the planned 400. The current literature continues to support the rationale for the trial. ARUBA is steadily approaching its monthly randomization goals and has already reached the number needed to test the maximum published interventional complication rates against the minimum hemorrhage rates for natural history.
Medical subject headings
- Intracranial Arteriovenous Malformations